📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Elucidating acquired PARP inhibitor resistance in advanced prostate cancer. (2024)

First Author: Seed G

Attributed to: BRCAREV: Unravelling how reversion mutations in the BRCA1 and BRCA2 tumour suppressor genes occur funded by Horizon Europe Guarantee

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ccell.2024.10.015

PubMed Identifier: 39577422

Publication URI: http://europepmc.org/abstract/MED/39577422

Type: Journal Article/Review

Volume: 42

Parent Publication: Cancer cell

Issue: 12

ISSN: 1535-6108